ERK1/2在大鼠心肌缺血预处理中的作用(2)
 |
| 第1页 |
参见附件。
[2] Curtis MJ.Model for the study of arrhythmias in the myocardial ischemia and infarction:The use of the rat[J].J Mol Cell Cardiol,1987，19:399419.
[3] Ravingerova T.Intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart:Relation between susceptibility to arrhythmias and degree of ultrastructural injury[J].J Mol Cell Cardiol,1995，27:19371951.
[4] 马彩云，张立克，杜凤和，等.细胞外信号调节的蛋白激酶对糖尿病大鼠心肌缺血预处理的影响[J].中国病理生理学杂志，2005，21(1)：6871.
[5] Strohm C,Barancil M,Brahl M,et al.Inhibition of ERKinase cascade by PD 098059 and U 0126 counteracta ischemic preconditioning in pig myocardium[J].Cardiovascular Research,2000，36:218229.
[6] Choid JS,Kim HY,Cha JH,et al.Ischemic preconditioninginduced activation of ERK1/2 in the rat hippocampus[J].Neurosci Lett，2006，409(3):187191.
[7] Zhang J,Bian HJ,Li XX,et al.ERKMAPK signaling opposes rhokinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning[J].Molecular Medicine,2010，16(78):307315.
[8] Ryan M,Fryer AK,Hsu GJ,et al.ERK and P38 MAP kinase activation are components of opioidinduced delayed cardioprotection[J].Basic Research in Cardiology,2001,96(2)：136142.
[9] Namura S,Lihara K,Takami S,et al.Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia[J].Proc Natl Acad Sci USA,2001,12:34873491.
作者简介：马彩云(1976—)，女，毕业于首都医科大学，主治医师，硕士研究生，现工作于航空总医院(邮编：100012)；李远征，工作于航空总医院；杜凤和，工作于首都医科大学附属北京天坛医院。
(收稿日期：20120328)
(本文编辑郭怀印)
您现在查看是摘要介绍页，详见PDF附件(1851kb)。